title: Monitoring safety and effectiveness in patients receiving metformin.
authors.forename: Hae Mi
authors.initials: HM
authors.lastname: Choe
authors.forename: Laura
authors.initials: L
authors.lastname: Cornish
authors.forename: Kevin
authors.initials: K
authors.lastname: Townsend
authors.forename: Jeff
authors.initials: J
authors.lastname: Jobe
authors.forename: Sonya
authors.initials: S
authors.lastname: Mitrovich
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D016903:Drug Monitoring; D017723:Drug Utilization Review; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008687:Metformin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D013453:Sulfonylurea Compounds